Gaucher disease and cancer incidence: a study from the Gaucher Registry

Author:

Rosenbloom Barry E.1,Weinreb Neal J.1,Zimran Ari1,Kacena Katherine A.1,Charrow Joel1,Ward Elizabeth1

Affiliation:

1. From the Tower Hematology Oncology Medical Group, Beverly Hills, CA; the University Research Foundation for Lysosomal Storage Diseases, Coral Springs, FL; the Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel; Genzyme Corporation, Cambridge, MA; the Division of Genetics, Children's Memorial Hospital, Department of Pediatrics, Feinberg School of Medicine of Northwestern University, Chicago, IL; and the American Cancer Society, Atlanta, GA.

Abstract

Abstract Patients with Gaucher disease (GD) are alleged to be at an increased risk of malignant disorders, possibly due to potential chronic stimulation of the immune system and lymphoproliferation associated with storage of glucocerebroside in tissue macrophages. Because previous reports of increased risk of malignancy in GD may have been affected by small patient numbers and ascertainment bias, 2742 patients with GD from the International Gaucher Registry were studied. The number of cancers identified among patients in the registry was compared with that expected in the US population of similar attained age and sex. The majority of patients were young or middle-aged adults at the time of last follow-up, with only 14% older than age 60. There were 10 patients with multiple myeloma, yielding an estimated relative risk of 5.9 (95% confidence interval [95% CI]: 2.8, 10.8). The relative risk of cancer overall was 0.79 (95% CI: 0.67, 0.94), and the subgroups for cancers of the breast, prostate, colon and rectum, lung, and hematologic malignancies other than myeloma did not yield statistically significant higher risks. This study suggests that, in general, patients with Gaucher disease are not at highly increased risk of cancer, at least during early and middle age. However, there appears to be a significantly higher risk of multiple myeloma of which physicians should be aware when caring for these patients. (Blood. 2005;105:4569-4572)

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference53 articles.

1. Beutler E, Grabowsli GA. Gaucher disease. In: Scriver CR, Valle D, Beudet A, Sly WS, eds. The Metabolic and Molecular Bases of Inherited Diseases. Vol III. New York, NY: McGraw-Hill; 2001: 3635-3668.

2. Lee RE. The pathology of Gaucher disease. In: Desnick RJ, Grabowski GA, eds. Gaucher Disease: A Century of Delineation and Research. New York, NY: Alan R. Liss; 1982: 177-217.

3. Shiran A, Brenner B, Laor A, et al. Increased risk of cancer in patients with Gaucher disease. Cancer.1993;72: 219-224.

4. Schoenfeld Y, Gallant LA, Shaklai M, et al, Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med.1982;106: 388-391.

5. Charrow J, Andersson HC, Kaplan P, et al, The Gaucher Registry: demographic and disease characteristics in patients with Gaucher disease. Arch Int Med.2000;160: 2835-2843.

Cited by 195 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3